2 x MAXIGRA GO 25MG 4 TABS — MADE IN POLAND — FREE SHIPPING

Maxigra Go 25mg 4 tablets.

It contains sildenafil - the most popular substance for erectile dysfunction.
Available over the counter in packs of 2 or 4 tablets.

Composition and form:

Each chewable tablet contains 25 mg of sildenafil formed in situ with 35.12 mg of sildenafil citrate. Excipients with known effect: Each tablet contains 2.15 mg of aspartame (E951) and 70.4575 mg of lactose monohydrate.

indications:

Maxigra Go is indicated in adult men with erectile dysfunction, i.e. the inability to obtain or maintain a penile erection sufficient for sexual activity. For Maxigra Go to work effectively, sexual stimulation is required.

Contraindications:

Hypersensitivity to the active substance or to any of the excipients. Due to the effect of sildenafil on metabolic transformations in which nitric oxide and cyclic guanosine monophosphate (cGMP) take part, it increases the hypotensive effect of nitrates. Concomitant use of sildenafil with preparations releasing nitric oxide (such as amyl nitrite) or any form of nitrates is therefore contraindicated. The concomitant use of PDE5 inhibitors, including sildenafil, and guanylate cyclase stimulants, such as riociguat, is contraindicated as it may lead to symptomatic hypotension. Medicinal products for the treatment of erectile dysfunction, including sildenafil, should not be used in men for whom sexual activity is inadvisable (e.g. patients with severe cardiovascular diseases such as unstable angina or severe heart failure). Maxigra Go is contraindicated in patients who have lost sight in one eye as a result of non-arteritic anterior ischemic optic neuropathy (NAION), whether related or not was related to prior exposure to a PDE5 inhibitor. The safety of sildenafil has not been studied in the following groups of patients: patients with severe hepatic insufficiency, hypotension (blood pressure <90/50 mmHg), recent stroke or myocardial infarction, and with known hereditary retinal degenerative changes such as retinitis pigmentosa (mild some of these patients have genetically determined abnormalities of the retinal phosphodiesterase). The use of sildenafil in these patients is contraindicated.

MAXIGRA GO. Use instruction.

Indications: Maxigra Go is a medicinal product indicated for use in adult men in the case of erectile dysfunction, i.e. the inability to obtain or maintain a penile erection sufficient for sexual intercourse. In order for Maxigra Go to work effectively, sexual stimulation is required.

Properties: Maxigra Go belongs to the group of phosphodiesterase type 5 (PDE5) inhibitors. It works by helping to relax the blood vessels in your penis and by increasing the flow of blood into your penis when you are sexually aroused. Maxigra Go will only help you to get an erection if you are sexually stimulated. It is used to treat male erectile dysfunction, also known as impotence. This medicine is presented as white, triangular, biconvex tablets, engraved with '25' on one side. The drug is available without a prescription!

Composition: Each chewable tablet contains 25 mg of sildenafil formed in situ with 35.12 mg of sildenafil citrate. Excipients with known effect: Each tablet contains 2.15 mg of aspartame (E951) and 70.4575 mg of lactose monohydrate.

Use: The drug should be used according to the doctor's instructions. If in doubt, consult your doctor or pharmacist. The recommended starting dose is 25 mg. Maxigra Go should not be used more than once a day. Take the Maxigra drug about an hour before planned sexual activity. Contact your doctor if you have taken more tablets than recommended. In case of any doubts regarding the use of the drug, consult a physician or pharmacist.

Important information: Maxigra Go is contraindicated in the case of:

- hypersensitivity to the active substance or to any of the excipients;

- concomitant use of drugs that release nitric oxide (such as amyl nitrite) or nitrates in any form;

- men for whom sexual activity is inadvisable (e.g. patients with severe cardiovascular diseases such as unstable angina or severe heart failure);

- patients who lost sight in one eye as a result of non-arteritic anteriorischaemic optic neuropathy (NAION), whether or not related to prior inhibitor exposure PDE5.

The concomitant use of PDE5 inhibitors, including sildenafil, and guanylate cyclase stimulants, such as riociguat, is contraindicated as it may lead to symptomatic hypotension.

The safety of sildenafil has not been studied in the following groups of patients: patients with severe hepatic insufficiency, hypotension (blood pressure <90/50 mm Hg), recent stroke or myocardial infarction, and with known hereditary retinal degenerative changes such as retinitis pigmentosa (a small proportion of these patients have genetically determined retinal phosphodiesterase abnormalities). The use of sildenafil in these patients is contraindicated.

Storage: Keep the drug out of the reach and sight of children.

Package: 4 tablets

Before use, read the leaflet, which contains indications, contraindications, data on side effects and dosage as well as information on the use of the medicinal product, or consult your doctor or pharmacist, as each drug used improperly is a threat to your life or health.